Global Nuclear Pharmacy Market Research Report 2026(Status and Outlook)
Nuclear pharmaceutical products, also known as radiopharmaceuticals, are a class of precise diagnostic or therapeutic agents formed by labeling radionuclides onto specific carrier molecules. Their core principle is to utilize the combination of radiation emitted by the radionuclide and the biological targeting properties of the drug carrier to achieve precise visualization of diseases or internal irradiation therapy. Based on their application, they can be divided into two main categories: diagnostic radiopharmaceuticals, which use single-photon emission computed tomography (SPECT) or positron emission tomography (PET) to detect tumors and cardiovascular diseases at an early stage at the cellular metabolic or molecular functional level; and therapeutic radiopharmaceuticals, which can precisely deliver radiation energy to diseased cells, achieving "targeted internal radiotherapy." The research and application of these products are highly interdisciplinary, involving nuclear physics, radiochemistry, pharmacy, and medicine. Their production, quality control, and use are subject to strict dual regulation by national drug regulatory agencies and nuclear safety departments.The nuclear pharmaceutical industry chain is a technology-intensive, strictly regulated, and highly collaborative specialized chain. The upstream is the core and bottleneck link, involving the production and supply of medical radionuclides. It relies on nuclear reactors or cyclotron irradiation targets to produce short-half-life radionuclides, and the stability of its supply is a global challenge. The midstream involves drug preparation, labeling, and quality control. Pharmaceutical companies or medical institutions rapidly and with high purity label the nuclide with specific precursor compounds in GMP-compliant and radiation-safe "hot chambers" or automated synthesis modules, completing rigorous sterility, pyrogen-free, radiochemical purity, and activity testing. This process is often measured in minutes or hours to address nuclide decay. The downstream involves clinical distribution and application. An efficient logistics network ensures timely delivery of products to hospital nuclear medicine departments, where specialized teams use them for patient imaging diagnosis or targeted therapy. The entire industry chain is interconnected and heavily reliant on a stable supply of nuclides, advanced labeling technology, a comprehensive quality control system, and close collaboration between pharmaceutical, medical device, and medical institutions.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Nuclear Pharmacy market size was estimated at USD 9611.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Pharmacy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Pharmacy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Pharmacy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Pharmacy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Pharmacy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Nuclear Pharmacy market size was estimated at USD 9611.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Pharmacy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Pharmacy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Pharmacy market.
Global Nuclear Pharmacy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Bayer
- Curium Pharma
- Jubilant Pharmova
- GE Healthcare
- Cardinal Health
- Eli Lilly
- Bracco Imaging
- China Isotope & Radiation
- Novartis
- Siemens
- Lantheus Medical Imaging
- Aurobindo Pharma
- ANSTO
- Polatom
- NTP Radioisotopes
- Yantai Dongcheng Pharmaceutical
- Saide Biotechnology
Market Segmentation (by Type)
- Diagnostic Products
- Therapeutic Products
Market Segmentation (by Application)
- Pharmaceutical
- Hospital
- Laboratory
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Pharmacy Market
Overview of the regional outlook of the Nuclear Pharmacy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Pharmacy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Pharmacy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Pharmacy
1.2 Key Market Segments
1.2.1 Nuclear Pharmacy Segment by Type
1.2.2 Nuclear Pharmacy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR PHARMACY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Pharmacy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Pharmacy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR PHARMACY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Pharmacy Product Life Cycle
3.3 Global Nuclear Pharmacy Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Pharmacy Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Pharmacy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Pharmacy Market Competitive Situation and Trends
3.8.1 Nuclear Pharmacy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Pharmacy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR PHARMACY INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Pharmacy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR PHARMACY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Pharmacy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Pharmacy Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR PHARMACY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Pharmacy Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Pharmacy Market Size by Type (2020-2025)
6.4 Global Nuclear Pharmacy Price by Type (2020-2025)
7 NUCLEAR PHARMACY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Pharmacy Market Sales by Application (2020-2025)
7.3 Global Nuclear Pharmacy Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
8 NUCLEAR PHARMACY MARKET SALES BY REGION
8.1 Global Nuclear Pharmacy Sales by Region
8.1.1 Global Nuclear Pharmacy Sales by Region
8.1.2 Global Nuclear Pharmacy Sales Market Share by Region
8.2 Global Nuclear Pharmacy Market Size by Region
8.2.1 Global Nuclear Pharmacy Market Size by Region
8.2.2 Global Nuclear Pharmacy Market Size by Region
8.3 North America
8.3.1 North America Nuclear Pharmacy Sales by Country
8.3.2 North America Nuclear Pharmacy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Pharmacy Sales by Country
8.4.2 Europe Nuclear Pharmacy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Pharmacy Sales by Region
8.5.2 Asia Pacific Nuclear Pharmacy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Pharmacy Sales by Country
8.6.2 South America Nuclear Pharmacy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Pharmacy Sales by Region
8.7.2 Middle East and Africa Nuclear Pharmacy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR PHARMACY MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Pharmacy by Region(2020-2025)
9.2 Global Nuclear Pharmacy Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Pharmacy Production
9.4.1 North America Nuclear Pharmacy Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Pharmacy Production
9.5.1 Europe Nuclear Pharmacy Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Pharmacy Production (2020-2025)
9.6.1 Japan Nuclear Pharmacy Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Pharmacy Production (2020-2025)
9.7.1 China Nuclear Pharmacy Production Growth Rate (2020-2025)
9.7.2 China Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Nuclear Pharmacy Product Overview
10.1.3 Bayer Nuclear Pharmacy Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Curium Pharma
10.2.1 Curium Pharma Basic Information
10.2.2 Curium Pharma Nuclear Pharmacy Product Overview
10.2.3 Curium Pharma Nuclear Pharmacy Product Market Performance
10.2.4 Curium Pharma Business Overview
10.2.5 Curium Pharma SWOT Analysis
10.2.6 Curium Pharma Recent Developments
10.3 Jubilant Pharmova
10.3.1 Jubilant Pharmova Basic Information
10.3.2 Jubilant Pharmova Nuclear Pharmacy Product Overview
10.3.3 Jubilant Pharmova Nuclear Pharmacy Product Market Performance
10.3.4 Jubilant Pharmova Business Overview
10.3.5 Jubilant Pharmova SWOT Analysis
10.3.6 Jubilant Pharmova Recent Developments
10.4 GE Healthcare
10.4.1 GE Healthcare Basic Information
10.4.2 GE Healthcare Nuclear Pharmacy Product Overview
10.4.3 GE Healthcare Nuclear Pharmacy Product Market Performance
10.4.4 GE Healthcare Business Overview
10.4.5 GE Healthcare Recent Developments
10.5 Cardinal Health
10.5.1 Cardinal Health Basic Information
10.5.2 Cardinal Health Nuclear Pharmacy Product Overview
10.5.3 Cardinal Health Nuclear Pharmacy Product Market Performance
10.5.4 Cardinal Health Business Overview
10.5.5 Cardinal Health Recent Developments
10.6 Eli Lilly
10.6.1 Eli Lilly Basic Information
10.6.2 Eli Lilly Nuclear Pharmacy Product Overview
10.6.3 Eli Lilly Nuclear Pharmacy Product Market Performance
10.6.4 Eli Lilly Business Overview
10.6.5 Eli Lilly Recent Developments
10.7 Bracco Imaging
10.7.1 Bracco Imaging Basic Information
10.7.2 Bracco Imaging Nuclear Pharmacy Product Overview
10.7.3 Bracco Imaging Nuclear Pharmacy Product Market Performance
10.7.4 Bracco Imaging Business Overview
10.7.5 Bracco Imaging Recent Developments
10.8 China Isotope and Radiation
10.8.1 China Isotope and Radiation Basic Information
10.8.2 China Isotope and Radiation Nuclear Pharmacy Product Overview
10.8.3 China Isotope and Radiation Nuclear Pharmacy Product Market Performance
10.8.4 China Isotope and Radiation Business Overview
10.8.5 China Isotope and Radiation Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Nuclear Pharmacy Product Overview
10.9.3 Novartis Nuclear Pharmacy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Siemens
10.10.1 Siemens Basic Information
10.10.2 Siemens Nuclear Pharmacy Product Overview
10.10.3 Siemens Nuclear Pharmacy Product Market Performance
10.10.4 Siemens Business Overview
10.10.5 Siemens Recent Developments
10.11 Lantheus Medical Imaging
10.11.1 Lantheus Medical Imaging Basic Information
10.11.2 Lantheus Medical Imaging Nuclear Pharmacy Product Overview
10.11.3 Lantheus Medical Imaging Nuclear Pharmacy Product Market Performance
10.11.4 Lantheus Medical Imaging Business Overview
10.11.5 Lantheus Medical Imaging Recent Developments
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Basic Information
10.12.2 Aurobindo Pharma Nuclear Pharmacy Product Overview
10.12.3 Aurobindo Pharma Nuclear Pharmacy Product Market Performance
10.12.4 Aurobindo Pharma Business Overview
10.12.5 Aurobindo Pharma Recent Developments
10.13 ANSTO
10.13.1 ANSTO Basic Information
10.13.2 ANSTO Nuclear Pharmacy Product Overview
10.13.3 ANSTO Nuclear Pharmacy Product Market Performance
10.13.4 ANSTO Business Overview
10.13.5 ANSTO Recent Developments
10.14 Polatom
10.14.1 Polatom Basic Information
10.14.2 Polatom Nuclear Pharmacy Product Overview
10.14.3 Polatom Nuclear Pharmacy Product Market Performance
10.14.4 Polatom Business Overview
10.14.5 Polatom Recent Developments
10.15 NTP Radioisotopes
10.15.1 NTP Radioisotopes Basic Information
10.15.2 NTP Radioisotopes Nuclear Pharmacy Product Overview
10.15.3 NTP Radioisotopes Nuclear Pharmacy Product Market Performance
10.15.4 NTP Radioisotopes Business Overview
10.15.5 NTP Radioisotopes Recent Developments
10.16 Yantai Dongcheng Pharmaceutical
10.16.1 Yantai Dongcheng Pharmaceutical Basic Information
10.16.2 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Overview
10.16.3 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Market Performance
10.16.4 Yantai Dongcheng Pharmaceutical Business Overview
10.16.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.17 Saide Biotechnology
10.17.1 Saide Biotechnology Basic Information
10.17.2 Saide Biotechnology Nuclear Pharmacy Product Overview
10.17.3 Saide Biotechnology Nuclear Pharmacy Product Market Performance
10.17.4 Saide Biotechnology Business Overview
10.17.5 Saide Biotechnology Recent Developments
11 NUCLEAR PHARMACY MARKET FORECAST BY REGION
11.1 Global Nuclear Pharmacy Market Size Forecast
11.2 Global Nuclear Pharmacy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Pharmacy Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Pharmacy Market Size Forecast by Region
11.2.4 South America Nuclear Pharmacy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Pharmacy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Pharmacy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Pharmacy by Type (2026-2035)
12.1.2 Global Nuclear Pharmacy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Pharmacy by Type (2026-2035)
12.2 Global Nuclear Pharmacy Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Pharmacy Sales (K Units) Forecast by Application
12.2.2 Global Nuclear Pharmacy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Pharmacy
1.2 Key Market Segments
1.2.1 Nuclear Pharmacy Segment by Type
1.2.2 Nuclear Pharmacy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR PHARMACY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Pharmacy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Pharmacy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR PHARMACY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Pharmacy Product Life Cycle
3.3 Global Nuclear Pharmacy Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Pharmacy Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Pharmacy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Pharmacy Market Competitive Situation and Trends
3.8.1 Nuclear Pharmacy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Pharmacy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR PHARMACY INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Pharmacy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR PHARMACY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Pharmacy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Pharmacy Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR PHARMACY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Pharmacy Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Pharmacy Market Size by Type (2020-2025)
6.4 Global Nuclear Pharmacy Price by Type (2020-2025)
7 NUCLEAR PHARMACY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Pharmacy Market Sales by Application (2020-2025)
7.3 Global Nuclear Pharmacy Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
8 NUCLEAR PHARMACY MARKET SALES BY REGION
8.1 Global Nuclear Pharmacy Sales by Region
8.1.1 Global Nuclear Pharmacy Sales by Region
8.1.2 Global Nuclear Pharmacy Sales Market Share by Region
8.2 Global Nuclear Pharmacy Market Size by Region
8.2.1 Global Nuclear Pharmacy Market Size by Region
8.2.2 Global Nuclear Pharmacy Market Size by Region
8.3 North America
8.3.1 North America Nuclear Pharmacy Sales by Country
8.3.2 North America Nuclear Pharmacy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Pharmacy Sales by Country
8.4.2 Europe Nuclear Pharmacy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Pharmacy Sales by Region
8.5.2 Asia Pacific Nuclear Pharmacy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Pharmacy Sales by Country
8.6.2 South America Nuclear Pharmacy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Pharmacy Sales by Region
8.7.2 Middle East and Africa Nuclear Pharmacy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR PHARMACY MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Pharmacy by Region(2020-2025)
9.2 Global Nuclear Pharmacy Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Pharmacy Production
9.4.1 North America Nuclear Pharmacy Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Pharmacy Production
9.5.1 Europe Nuclear Pharmacy Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Pharmacy Production (2020-2025)
9.6.1 Japan Nuclear Pharmacy Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Pharmacy Production (2020-2025)
9.7.1 China Nuclear Pharmacy Production Growth Rate (2020-2025)
9.7.2 China Nuclear Pharmacy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Nuclear Pharmacy Product Overview
10.1.3 Bayer Nuclear Pharmacy Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Curium Pharma
10.2.1 Curium Pharma Basic Information
10.2.2 Curium Pharma Nuclear Pharmacy Product Overview
10.2.3 Curium Pharma Nuclear Pharmacy Product Market Performance
10.2.4 Curium Pharma Business Overview
10.2.5 Curium Pharma SWOT Analysis
10.2.6 Curium Pharma Recent Developments
10.3 Jubilant Pharmova
10.3.1 Jubilant Pharmova Basic Information
10.3.2 Jubilant Pharmova Nuclear Pharmacy Product Overview
10.3.3 Jubilant Pharmova Nuclear Pharmacy Product Market Performance
10.3.4 Jubilant Pharmova Business Overview
10.3.5 Jubilant Pharmova SWOT Analysis
10.3.6 Jubilant Pharmova Recent Developments
10.4 GE Healthcare
10.4.1 GE Healthcare Basic Information
10.4.2 GE Healthcare Nuclear Pharmacy Product Overview
10.4.3 GE Healthcare Nuclear Pharmacy Product Market Performance
10.4.4 GE Healthcare Business Overview
10.4.5 GE Healthcare Recent Developments
10.5 Cardinal Health
10.5.1 Cardinal Health Basic Information
10.5.2 Cardinal Health Nuclear Pharmacy Product Overview
10.5.3 Cardinal Health Nuclear Pharmacy Product Market Performance
10.5.4 Cardinal Health Business Overview
10.5.5 Cardinal Health Recent Developments
10.6 Eli Lilly
10.6.1 Eli Lilly Basic Information
10.6.2 Eli Lilly Nuclear Pharmacy Product Overview
10.6.3 Eli Lilly Nuclear Pharmacy Product Market Performance
10.6.4 Eli Lilly Business Overview
10.6.5 Eli Lilly Recent Developments
10.7 Bracco Imaging
10.7.1 Bracco Imaging Basic Information
10.7.2 Bracco Imaging Nuclear Pharmacy Product Overview
10.7.3 Bracco Imaging Nuclear Pharmacy Product Market Performance
10.7.4 Bracco Imaging Business Overview
10.7.5 Bracco Imaging Recent Developments
10.8 China Isotope and Radiation
10.8.1 China Isotope and Radiation Basic Information
10.8.2 China Isotope and Radiation Nuclear Pharmacy Product Overview
10.8.3 China Isotope and Radiation Nuclear Pharmacy Product Market Performance
10.8.4 China Isotope and Radiation Business Overview
10.8.5 China Isotope and Radiation Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Nuclear Pharmacy Product Overview
10.9.3 Novartis Nuclear Pharmacy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Siemens
10.10.1 Siemens Basic Information
10.10.2 Siemens Nuclear Pharmacy Product Overview
10.10.3 Siemens Nuclear Pharmacy Product Market Performance
10.10.4 Siemens Business Overview
10.10.5 Siemens Recent Developments
10.11 Lantheus Medical Imaging
10.11.1 Lantheus Medical Imaging Basic Information
10.11.2 Lantheus Medical Imaging Nuclear Pharmacy Product Overview
10.11.3 Lantheus Medical Imaging Nuclear Pharmacy Product Market Performance
10.11.4 Lantheus Medical Imaging Business Overview
10.11.5 Lantheus Medical Imaging Recent Developments
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Basic Information
10.12.2 Aurobindo Pharma Nuclear Pharmacy Product Overview
10.12.3 Aurobindo Pharma Nuclear Pharmacy Product Market Performance
10.12.4 Aurobindo Pharma Business Overview
10.12.5 Aurobindo Pharma Recent Developments
10.13 ANSTO
10.13.1 ANSTO Basic Information
10.13.2 ANSTO Nuclear Pharmacy Product Overview
10.13.3 ANSTO Nuclear Pharmacy Product Market Performance
10.13.4 ANSTO Business Overview
10.13.5 ANSTO Recent Developments
10.14 Polatom
10.14.1 Polatom Basic Information
10.14.2 Polatom Nuclear Pharmacy Product Overview
10.14.3 Polatom Nuclear Pharmacy Product Market Performance
10.14.4 Polatom Business Overview
10.14.5 Polatom Recent Developments
10.15 NTP Radioisotopes
10.15.1 NTP Radioisotopes Basic Information
10.15.2 NTP Radioisotopes Nuclear Pharmacy Product Overview
10.15.3 NTP Radioisotopes Nuclear Pharmacy Product Market Performance
10.15.4 NTP Radioisotopes Business Overview
10.15.5 NTP Radioisotopes Recent Developments
10.16 Yantai Dongcheng Pharmaceutical
10.16.1 Yantai Dongcheng Pharmaceutical Basic Information
10.16.2 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Overview
10.16.3 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Market Performance
10.16.4 Yantai Dongcheng Pharmaceutical Business Overview
10.16.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.17 Saide Biotechnology
10.17.1 Saide Biotechnology Basic Information
10.17.2 Saide Biotechnology Nuclear Pharmacy Product Overview
10.17.3 Saide Biotechnology Nuclear Pharmacy Product Market Performance
10.17.4 Saide Biotechnology Business Overview
10.17.5 Saide Biotechnology Recent Developments
11 NUCLEAR PHARMACY MARKET FORECAST BY REGION
11.1 Global Nuclear Pharmacy Market Size Forecast
11.2 Global Nuclear Pharmacy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Pharmacy Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Pharmacy Market Size Forecast by Region
11.2.4 South America Nuclear Pharmacy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Pharmacy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Pharmacy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Pharmacy by Type (2026-2035)
12.1.2 Global Nuclear Pharmacy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Pharmacy by Type (2026-2035)
12.2 Global Nuclear Pharmacy Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Pharmacy Sales (K Units) Forecast by Application
12.2.2 Global Nuclear Pharmacy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Pharmacy Market Size by Type (M USD)
Table 4. Global Nuclear Pharmacy Market Size by Application
Table 5. Nuclear Pharmacy Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Pharmacy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nuclear Pharmacy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Pharmacy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Pharmacy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2025)
Table 11. Global Market Nuclear Pharmacy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Nuclear Pharmacy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Pharmacy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Pharmacy Sales by Type (K Units)
Table 27. Global Nuclear Pharmacy Market Size by Type (M USD)
Table 28. Global Nuclear Pharmacy Sales (K Units) by Type (2020-2025)
Table 29. Global Nuclear Pharmacy Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Pharmacy Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Pharmacy Market Share by Type (2020-2025)
Table 32. Global Nuclear Pharmacy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nuclear Pharmacy Sales (K Units) by Application
Table 34. Global Nuclear Pharmacy Market Size by Application
Table 35. Global Nuclear Pharmacy Sales by Application (2020-2025) & (K Units)
Table 36. Global Nuclear Pharmacy Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Pharmacy Market Share by Application (2020-2025)
Table 39. Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 41. Global Nuclear Pharmacy Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Pharmacy Market Size by Region (2020-2025)
Table 44. North America Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 45. North America Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 51. South America Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Pharmacy Production (K Units) by Region(2020-2025)
Table 55. Global Nuclear Pharmacy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Pharmacy Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Nuclear Pharmacy Product Overview
Table 64. Bayer Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Curium Pharma Basic Information
Table 69. Curium Pharma Nuclear Pharmacy Product Overview
Table 70. Curium Pharma Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Curium Pharma Business Overview
Table 72. Curium Pharma SWOT Analysis
Table 73. Curium Pharma Recent Developments
Table 74. Jubilant Pharmova Basic Information
Table 75. Jubilant Pharmova Nuclear Pharmacy Product Overview
Table 76. Jubilant Pharmova Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Jubilant Pharmova Business Overview
Table 78. Jubilant Pharmova SWOT Analysis
Table 79. Jubilant Pharmova Recent Developments
Table 80. GE Healthcare Basic Information
Table 81. GE Healthcare Nuclear Pharmacy Product Overview
Table 82. GE Healthcare Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Recent Developments
Table 85. Cardinal Health Basic Information
Table 86. Cardinal Health Nuclear Pharmacy Product Overview
Table 87. Cardinal Health Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Recent Developments
Table 90. Eli Lilly Basic Information
Table 91. Eli Lilly Nuclear Pharmacy Product Overview
Table 92. Eli Lilly Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Recent Developments
Table 95. Bracco Imaging Basic Information
Table 96. Bracco Imaging Nuclear Pharmacy Product Overview
Table 97. Bracco Imaging Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bracco Imaging Business Overview
Table 99. Bracco Imaging Recent Developments
Table 100. China Isotope and Radiation Basic Information
Table 101. China Isotope and Radiation Nuclear Pharmacy Product Overview
Table 102. China Isotope and Radiation Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. China Isotope and Radiation Business Overview
Table 104. China Isotope and Radiation Recent Developments
Table 105. Novartis Basic Information
Table 106. Novartis Nuclear Pharmacy Product Overview
Table 107. Novartis Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Novartis Business Overview
Table 109. Novartis Recent Developments
Table 110. Siemens Basic Information
Table 111. Siemens Nuclear Pharmacy Product Overview
Table 112. Siemens Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Siemens Business Overview
Table 114. Siemens Recent Developments
Table 115. Lantheus Medical Imaging Basic Information
Table 116. Lantheus Medical Imaging Nuclear Pharmacy Product Overview
Table 117. Lantheus Medical Imaging Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Lantheus Medical Imaging Business Overview
Table 119. Lantheus Medical Imaging Recent Developments
Table 120. Aurobindo Pharma Basic Information
Table 121. Aurobindo Pharma Nuclear Pharmacy Product Overview
Table 122. Aurobindo Pharma Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Business Overview
Table 124. Aurobindo Pharma Recent Developments
Table 125. ANSTO Basic Information
Table 126. ANSTO Nuclear Pharmacy Product Overview
Table 127. ANSTO Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. ANSTO Business Overview
Table 129. ANSTO Recent Developments
Table 130. Polatom Basic Information
Table 131. Polatom Nuclear Pharmacy Product Overview
Table 132. Polatom Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Polatom Business Overview
Table 134. Polatom Recent Developments
Table 135. NTP Radioisotopes Basic Information
Table 136. NTP Radioisotopes Nuclear Pharmacy Product Overview
Table 137. NTP Radioisotopes Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. NTP Radioisotopes Business Overview
Table 139. NTP Radioisotopes Recent Developments
Table 140. Yantai Dongcheng Pharmaceutical Basic Information
Table 141. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Overview
Table 142. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Yantai Dongcheng Pharmaceutical Business Overview
Table 144. Yantai Dongcheng Pharmaceutical Recent Developments
Table 145. Saide Biotechnology Basic Information
Table 146. Saide Biotechnology Nuclear Pharmacy Product Overview
Table 147. Saide Biotechnology Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Saide Biotechnology Business Overview
Table 149. Saide Biotechnology Recent Developments
Table 150. Global Nuclear Pharmacy Sales Forecast by Region (2026-2035) & (K Units)
Table 151. Global Nuclear Pharmacy Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 153. North America Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 155. Europe Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Nuclear Pharmacy Sales Forecast by Region (2026-2035) & (K Units)
Table 157. Asia Pacific Nuclear Pharmacy Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 159. South America Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Nuclear Pharmacy Sales Forecast by Type (2026-2035) & (K Units)
Table 163. Global Nuclear Pharmacy Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Nuclear Pharmacy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 165. Global Nuclear Pharmacy Sales (K Units) Forecast by Application (2026-2035)
Table 166. Global Nuclear Pharmacy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Pharmacy Market Size by Type (M USD)
Table 4. Global Nuclear Pharmacy Market Size by Application
Table 5. Nuclear Pharmacy Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Pharmacy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nuclear Pharmacy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Pharmacy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Pharmacy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2025)
Table 11. Global Market Nuclear Pharmacy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Nuclear Pharmacy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Pharmacy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Pharmacy Sales by Type (K Units)
Table 27. Global Nuclear Pharmacy Market Size by Type (M USD)
Table 28. Global Nuclear Pharmacy Sales (K Units) by Type (2020-2025)
Table 29. Global Nuclear Pharmacy Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Pharmacy Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Pharmacy Market Share by Type (2020-2025)
Table 32. Global Nuclear Pharmacy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nuclear Pharmacy Sales (K Units) by Application
Table 34. Global Nuclear Pharmacy Market Size by Application
Table 35. Global Nuclear Pharmacy Sales by Application (2020-2025) & (K Units)
Table 36. Global Nuclear Pharmacy Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Pharmacy Market Share by Application (2020-2025)
Table 39. Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 41. Global Nuclear Pharmacy Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Pharmacy Market Size by Region (2020-2025)
Table 44. North America Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 45. North America Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Pharmacy Sales by Country (2020-2025) & (K Units)
Table 51. South America Nuclear Pharmacy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Pharmacy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nuclear Pharmacy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Pharmacy Production (K Units) by Region(2020-2025)
Table 55. Global Nuclear Pharmacy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Pharmacy Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nuclear Pharmacy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Nuclear Pharmacy Product Overview
Table 64. Bayer Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Curium Pharma Basic Information
Table 69. Curium Pharma Nuclear Pharmacy Product Overview
Table 70. Curium Pharma Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Curium Pharma Business Overview
Table 72. Curium Pharma SWOT Analysis
Table 73. Curium Pharma Recent Developments
Table 74. Jubilant Pharmova Basic Information
Table 75. Jubilant Pharmova Nuclear Pharmacy Product Overview
Table 76. Jubilant Pharmova Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Jubilant Pharmova Business Overview
Table 78. Jubilant Pharmova SWOT Analysis
Table 79. Jubilant Pharmova Recent Developments
Table 80. GE Healthcare Basic Information
Table 81. GE Healthcare Nuclear Pharmacy Product Overview
Table 82. GE Healthcare Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Recent Developments
Table 85. Cardinal Health Basic Information
Table 86. Cardinal Health Nuclear Pharmacy Product Overview
Table 87. Cardinal Health Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Recent Developments
Table 90. Eli Lilly Basic Information
Table 91. Eli Lilly Nuclear Pharmacy Product Overview
Table 92. Eli Lilly Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Recent Developments
Table 95. Bracco Imaging Basic Information
Table 96. Bracco Imaging Nuclear Pharmacy Product Overview
Table 97. Bracco Imaging Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bracco Imaging Business Overview
Table 99. Bracco Imaging Recent Developments
Table 100. China Isotope and Radiation Basic Information
Table 101. China Isotope and Radiation Nuclear Pharmacy Product Overview
Table 102. China Isotope and Radiation Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. China Isotope and Radiation Business Overview
Table 104. China Isotope and Radiation Recent Developments
Table 105. Novartis Basic Information
Table 106. Novartis Nuclear Pharmacy Product Overview
Table 107. Novartis Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Novartis Business Overview
Table 109. Novartis Recent Developments
Table 110. Siemens Basic Information
Table 111. Siemens Nuclear Pharmacy Product Overview
Table 112. Siemens Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Siemens Business Overview
Table 114. Siemens Recent Developments
Table 115. Lantheus Medical Imaging Basic Information
Table 116. Lantheus Medical Imaging Nuclear Pharmacy Product Overview
Table 117. Lantheus Medical Imaging Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Lantheus Medical Imaging Business Overview
Table 119. Lantheus Medical Imaging Recent Developments
Table 120. Aurobindo Pharma Basic Information
Table 121. Aurobindo Pharma Nuclear Pharmacy Product Overview
Table 122. Aurobindo Pharma Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Business Overview
Table 124. Aurobindo Pharma Recent Developments
Table 125. ANSTO Basic Information
Table 126. ANSTO Nuclear Pharmacy Product Overview
Table 127. ANSTO Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. ANSTO Business Overview
Table 129. ANSTO Recent Developments
Table 130. Polatom Basic Information
Table 131. Polatom Nuclear Pharmacy Product Overview
Table 132. Polatom Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Polatom Business Overview
Table 134. Polatom Recent Developments
Table 135. NTP Radioisotopes Basic Information
Table 136. NTP Radioisotopes Nuclear Pharmacy Product Overview
Table 137. NTP Radioisotopes Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. NTP Radioisotopes Business Overview
Table 139. NTP Radioisotopes Recent Developments
Table 140. Yantai Dongcheng Pharmaceutical Basic Information
Table 141. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product Overview
Table 142. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Yantai Dongcheng Pharmaceutical Business Overview
Table 144. Yantai Dongcheng Pharmaceutical Recent Developments
Table 145. Saide Biotechnology Basic Information
Table 146. Saide Biotechnology Nuclear Pharmacy Product Overview
Table 147. Saide Biotechnology Nuclear Pharmacy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Saide Biotechnology Business Overview
Table 149. Saide Biotechnology Recent Developments
Table 150. Global Nuclear Pharmacy Sales Forecast by Region (2026-2035) & (K Units)
Table 151. Global Nuclear Pharmacy Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 153. North America Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 155. Europe Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Nuclear Pharmacy Sales Forecast by Region (2026-2035) & (K Units)
Table 157. Asia Pacific Nuclear Pharmacy Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (K Units)
Table 159. South America Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Nuclear Pharmacy Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Nuclear Pharmacy Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Nuclear Pharmacy Sales Forecast by Type (2026-2035) & (K Units)
Table 163. Global Nuclear Pharmacy Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Nuclear Pharmacy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 165. Global Nuclear Pharmacy Sales (K Units) Forecast by Application (2026-2035)
Table 166. Global Nuclear Pharmacy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Pharmacy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Pharmacy Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Pharmacy Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Pharmacy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Pharmacy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Pharmacy Product Life Cycle
Figure 13. Nuclear Pharmacy Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Pharmacy Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Pharmacy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Pharmacy Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Pharmacy
Figure 19. Global Nuclear Pharmacy Market PEST Analysis
Figure 20. Global Nuclear Pharmacy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Pharmacy Market Share by Type
Figure 27. Sales Market Share of Nuclear Pharmacy by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Pharmacy by Type in 2025
Figure 29. Market Share of Nuclear Pharmacy by Type (2020-2025)
Figure 30. Market Share of Nuclear Pharmacy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Pharmacy Market Share by Application
Figure 33. Global Nuclear Pharmacy Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Pharmacy Sales Market Share by Application in 2025
Figure 35. Global Nuclear Pharmacy Market Share by Application (2020-2025)
Figure 36. Global Nuclear Pharmacy Market Share by Application in 2025
Figure 37. Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Pharmacy Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Pharmacy Market Size by Region (2020-2025)
Figure 40. North America Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 43. North America Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Pharmacy Market Size by Country in 2024
Figure 45. U.S. Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Pharmacy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Pharmacy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Pharmacy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Pharmacy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Pharmacy Market Size by Country in 2024
Figure 55. Germany Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nuclear Pharmacy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Pharmacy Market Size by Region in 2024
Figure 68. China Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 79. South America Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 80. South America Nuclear Pharmacy Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Pharmacy Market Size by Country in 2024
Figure 82. Brazil Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nuclear Pharmacy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Pharmacy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Pharmacy Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Pharmacy Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nuclear Pharmacy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nuclear Pharmacy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Pharmacy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Pharmacy Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Pharmacy Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Pharmacy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nuclear Pharmacy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Pharmacy Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Pharmacy Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Pharmacy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Pharmacy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Pharmacy Product Life Cycle
Figure 13. Nuclear Pharmacy Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Pharmacy Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Pharmacy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Pharmacy Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Pharmacy
Figure 19. Global Nuclear Pharmacy Market PEST Analysis
Figure 20. Global Nuclear Pharmacy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Pharmacy Market Share by Type
Figure 27. Sales Market Share of Nuclear Pharmacy by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Pharmacy by Type in 2025
Figure 29. Market Share of Nuclear Pharmacy by Type (2020-2025)
Figure 30. Market Share of Nuclear Pharmacy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Pharmacy Market Share by Application
Figure 33. Global Nuclear Pharmacy Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Pharmacy Sales Market Share by Application in 2025
Figure 35. Global Nuclear Pharmacy Market Share by Application (2020-2025)
Figure 36. Global Nuclear Pharmacy Market Share by Application in 2025
Figure 37. Global Nuclear Pharmacy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Pharmacy Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Pharmacy Market Size by Region (2020-2025)
Figure 40. North America Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 43. North America Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Pharmacy Market Size by Country in 2024
Figure 45. U.S. Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Pharmacy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Pharmacy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Pharmacy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Pharmacy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Pharmacy Market Size by Country in 2024
Figure 55. Germany Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nuclear Pharmacy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Pharmacy Market Size by Region in 2024
Figure 68. China Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 79. South America Nuclear Pharmacy Sales Market Share by Country in 2024
Figure 80. South America Nuclear Pharmacy Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Pharmacy Market Size by Country in 2024
Figure 82. Brazil Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Pharmacy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nuclear Pharmacy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Pharmacy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Pharmacy Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Pharmacy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nuclear Pharmacy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Pharmacy Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nuclear Pharmacy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nuclear Pharmacy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nuclear Pharmacy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Pharmacy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Pharmacy Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Pharmacy Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Pharmacy Market Share Forecast by Application (2026-2035)
More Publications
Global Sterilization Trays Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
149 pages
Global Parasite Cleanse Market Research Report 2024(Status and Outlook)
US$ 3,200.00
October 2026
117 pages
Global Kcnq4 Antibody Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
146 pages
Global Vitamin C Capsules Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
159 pages
Global Encephalitis Vaccination Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
137 pages
